脉冲场消融正在快速扩张：实时医生洞察揭示

Pulsed Field Ablation is Scaling Fast— Here’s What Real-Time PhysicianInsights Reveal Combining real-world data and IQVIA MedTech Quick Pulse Surveysinsights to understand one of MedTech’s fastest-moving innovations Table of contents IQVIA MedTech Quick Pulse Surveys — capturing a market in motion, in real time2A breakthrough technology — adopted at unprecedented speed2What physicians are telling us — and why it matters2Beyond adoption: The competitive shift has already begun3Why PFA Is winning: Physician experience tells the story3The next frontier: Site-of-care transformation4The bigger lesson: Speed of insight is now a competitive advantage4How Quick Pulse Surveys powers smarter decisions4Start the conversation5 Atrial Fibrillation (AF) is the most common cardiac arrhythmia, affecting millions ofpatients worldwide and significantly increasing the risk of stroke — by as much asfivefold in some populations. As the global burden of AF continues to grow, so does the need for more effectiveand efficient treatment options. One of the most promising advancementsis Pulsed Field Ablation (PFA), a next-generation technique that is not onlytransforming how procedures are performed but also influencing long-termpatient outcomes. Innovation in MedTech rarely moves fast. New technologies typically take years -sometimes decades — to move from early adoption to standard of care. But everyso often, something breaks that pattern. PFA is one of those moments! And what’s even more remarkable than the speed ofadoption is how quickly we’re able to understandwhyit’s happening. Why PFA Is winning: Physician experience tells the story Physicians report strong satisfaction across: Safety This aligns directly with the technology’s value proposition — and explains the speed of adoption. Satisfaction ratings of PFA, across all brands But there’s also nuance emerging. •67%of procedures use mapping today •Expected to drop to~55%within a year This signals potential disruption beyond devices into adjacent technologies and workflows. The next frontier: Site-of-care transformation PFA isn’t just changinghowprocedures are done, it may changewherethey’re done. Overall interest level in performing cardiac ablations in the ASC with 2026 CPL changes •Many respondents are skeptical of performing cardiac ablations in the ASC •Safety concerns remain the primary barrier This creates a complex, evolving landscape with opportunity for cost reduction and patient convenience balanced byclinical and operational uncertainty. The bigger lesson: Speed of insight is now a competitive advantage The PFA story highlights a broader shift in MedTech. It’s no longer enough to understand the market — you need both a comprehensive view of what’s happening and real-time insight into why it’s happening. Traditional approaches alone can’t keep pace with: This is where the IQVIA MedTech Quick Pulse Surveys becomes essential. How Quick Pulse Surveys powers smarter decisions The Quick Pulse Surveys is designed specifically for moments like this. It enables MedTech leaders to: •How is adoption evolving?•What drives physician choice?•Where is the market heading next? •Move at the speed of the market — capturingactionable insights in days, not months CONTACT USmeddevice@IQVIA.comiqviamedtech.com